Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL. Tomasulo E, Paul S, Mu R, Tian X, et al. Leuk Lymphoma 2023;64:2306-2315.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tomasulo E, Paul S, Mu R, Tian X, et al. Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL. Leuk Lymphoma 2023;64:2306-2315.
PMID: 37732614